Overview

Transfusion of Red Blood Cells, Tranexamic Acid and Fibrinogen Concentrate for Severe Trauma Hemorrhage at Pre-hospital Phase of Care.

Status:
Recruiting

Trial end date:
2021-12-31

Target enrollment:

Participant gender:

Summary

This is a single-center, not-randomized, open-label, controlled pilot clinical trial. This study compares presence of Trauma Induced Coagulopathy (TIC) and acute traumatic hemorrhage treatment at pre-hospital phase of care with red blood cells (RBC), Tranexamic acid (TXA) and Fibrinogen Concentrate (FC) with the current treatment based on the administration of Crystalloids and TXA.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Banc de Sang i Teixits

Collaborators:

IDIBGI (Institut d'Investigació Biomèdica de Girona Dr. Trueta)
Sistema d'Emergències Mèdiques (SEM)

Treatments:

Tranexamic Acid